2026-07-21T20:06:52Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/176342025-04-25T09:22:51Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16927col_20.500.12105_16978

00925njm 22002777a 4500 dc Lopez-de-Andres, Ana author Perez-Farinos, Napoleon author de Miguel-Diez, Javier author Hernandez-Barrera, Valentin author Méndez-Bailón, Manuel author de Miguel-Yanes, José M author Jiménez-García, Rodrigo author 2018-10-16 The aims of this study were to examine trends in the incidence and in-hospital outcomes of SAVR among T2DM patients from 2001 to 2015, to compare clinical variables among T2DM patients and matched non-T2DM patients hospitalized for SAVR and to identify factors associated with in-hospital mortality (IHM) among T2DM patients. We performed a retrospective study using the Spanish National Hospital Discharge Database, 2001-2015. We included patients who had SAVR as the procedure in their discharge report. For each T2DM patient, we selected a sex-, age-, implanted valve type- and year-matched nondiabetic patient. We identified 78,223 patients who underwent SAVR (23.49% with T2DM). The prevalence of T2DM increased significantly (p  The incidence of SAVR was higher in T2DM patients, and the incidence of bioprosthetic SAVR increased significantly among T2DM subjects. IHM decreased over time, regardless of the existence or absence of T2DM and the valve type. IHM was significantly lower in T2DM patients than in nondiabetic patients who underwent bioprosthetic SAVR. 10.1186/s12933-018-0780-2 1475-2840 Cardiovascular diabetology http://hdl.handle.net/10668/13093 30326902 http://hdl.handle.net/20.500.12105/17634 Hospitalization In-hospital mortality Surgical aortic valve replacement Type 2 diabetes mellitus Impact of type 2 diabetes mellitus in the utilization and in-hospital outcomes of surgical aortic valve replacement in Spain (2001-2015).